Showing results (641-650 of 664) with videos related to
Sort By:
Pageof 67
Science (New York, N.Y.)|July 4, 2015
Heavy fermions. Unconventional Fermi surface in an insulating stateB S Tan, Y-T Hsu, B Zeng, et al.Transplantation and Cellular Therapy|November 28, 2022
Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant ResearchM L Schoettler, E Carreras, B Cho, et al.Nature Communications|May 16, 2013
Anisotropic two-dimensional electron gas at the LaAlO₃/SrTiO₃ (110) interfaceA Annadi, Q Zhang, X Renshaw Wang, et al.Journal of Thrombosis and Haemostasis : JTH|September 9, 2014
Recombinant factor VIII Fc fusion protein: extended-interval dosing maintains low bleeding rates and correlates with von Willebrand factor levelsA D Shapiro, M V Ragni, R Kulkarni, et al.Schizophrenia Research|February 2, 2023
The SPEAK study rationale and design: A linguistic corpus-based approach to understanding thought disorderJ M M Bayer, J Spark, M Krcmar, et al.Journal for Immunotherapy of Cancer|September 9, 2020
Cell-based artificial APC resistant to lentiviral transduction for efficient generation of CAR-T cells from various cell sourcesAndrea Schmidts, Leah C Marsh, Ambike A Srivastava, et al.Genome Research|March 1, 1997
X chromosome map at 75-kb STS resolution, revealing extremes of recombination and GC contentR Nagaraja, S MacMillan, J Kere, et al.Nature Communications|May 9, 2024
Prediction of m6A and m5C at single-molecule resolution reveals a transcriptome-wide co-occurrence of RNA modificationsP Acera Mateos, A J Sethi, A Ravindran, et al.Journal of Thrombosis and Haemostasis : JTH|August 8, 2006
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand FactorJ E Sadler, U Budde, J C J Eikenboom, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 11, 2012
Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinomaJ M Pipas, B I Zaki, M M McGowan, et al.Pageof 67